Borze India Medical Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-12-2024
- Paid Up Capital ₹ 0.10 M
as on 17-12-2024
- Company Age 11 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 19.65%
(FY 2020)
- Profit 26.13%
(FY 2020)
- Ebitda 91.26%
(FY 2020)
- Net Worth 0.50%
(FY 2020)
- Total Assets 14.88%
(FY 2020)
About Borze India Medical
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Arvind Bindal and Namit Agnihotri serve as directors at the Company.
- CIN/LLPIN
U51909DL2013PTC252655
- Company No.
252655
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 May 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Borze India Medical?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arvind Bindal  | Director | 24-May-2013 | Current |
| Namit Agnihotri | Director | 24-May-2013 | Current |
Financial Performance of Borze India Medical.
Borze India Medical Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 19.65% increase. The company also saw a substantial improvement in profitability, with a 26.13% increase in profit. The company's net worth moved up by a moderate rise of 0.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Borze India Medical?
In 2020, Borze India Medical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Borze India Private LimitedActive 13 years 3 monthsArvind Bindal and Namit Agnihotri are mutual person
Heager India Private LimitedActive 10 years 2 monthsArvind Bindal and Namit Agnihotri are mutual person
- Bmv Meditech Private LimitedActive 12 years 3 months
Arvind Bindal and Namit Agnihotri are mutual person
- Maxcare Medical Systems Private LimitedActive 17 years 10 days
Arvind Bindal and Namit Agnihotri are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Borze India Medical?
Unlock and access historical data on people associated with Borze India Medical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Borze India Medical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Borze India Medical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
